Chengbin Wu

3.4k total citations · 1 hit paper
46 papers, 2.7k citations indexed

About

Chengbin Wu is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Chengbin Wu has authored 46 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Chengbin Wu's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (7 papers). Chengbin Wu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (7 papers). Chengbin Wu collaborates with scholars based in United States, China and United Kingdom. Chengbin Wu's co-authors include Cox Terhorst, Joan Sayós, Duncan Howie, Luigi D. Notarangelo, J E de Vries, Hans C. Oettgen, Deonie Allen, Gregorio Aversa, Maria‐Grazia Roncarolo and Raif S. Geha and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Chengbin Wu

44 papers receiving 2.6k citations

Hit Papers

The X-linked lymphoproliferative-disease gene product SAP... 1998 2026 2007 2016 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
    1998 746 citations Joan Sayós, Chengbin Wu et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengbin Wu United States 20 1.4k 653 534 419 307 46 2.7k
T. Boone United States 31 1.3k 1.0× 1.3k 2.0× 749 1.4× 525 1.3× 226 0.7× 89 4.3k
Masanori Shinohara Japan 35 705 0.5× 1.5k 2.3× 1.4k 2.7× 187 0.4× 184 0.6× 196 4.3k
Thomas Matthes Switzerland 25 902 0.7× 597 0.9× 387 0.7× 117 0.3× 438 1.4× 76 2.2k
Hideyuki Ikeda Japan 24 1.3k 1.0× 1.6k 2.4× 959 1.8× 102 0.2× 154 0.5× 97 3.4k
Andreas Bruckbauer United Kingdom 33 1.2k 0.9× 1.2k 1.8× 222 0.4× 256 0.6× 55 0.2× 54 3.5k
Tadayuki Yago United States 35 1.4k 1.1× 1.4k 2.2× 593 1.1× 332 0.8× 858 2.8× 58 4.6k
Kei Takahashi Japan 30 390 0.3× 744 1.1× 305 0.6× 122 0.3× 124 0.4× 166 3.4k
Elmar Endl Germany 37 1.2k 0.9× 2.7k 4.2× 738 1.4× 106 0.3× 249 0.8× 75 4.9k
Björn Önfelt Sweden 36 1.7k 1.3× 1.7k 2.6× 1.4k 2.6× 150 0.4× 172 0.6× 98 4.7k
Johannes W.G. Janssen Germany 34 577 0.4× 1.9k 2.9× 688 1.3× 317 0.8× 827 2.7× 87 4.1k

Countries citing papers authored by Chengbin Wu

Since Specialization
Citations

This map shows the geographic impact of Chengbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbin Wu more than expected).

Fields of papers citing papers by Chengbin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbin Wu. The network helps show where Chengbin Wu may publish in the future.

Co-authorship network of co-authors of Chengbin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengbin Wu. A scholar is included among the top collaborators of Chengbin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengbin Wu. Chengbin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaowa, Naren, et al.. (2025). Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy. Molecular Cancer Therapeutics. 24(10). 1600–1610.
2.
3.
4.
Liu, Hongyan, Chengbin Wu, Yu Zhao, et al.. (2023). Exploring health literacy in patients with chronic diseases in Chongqing, China: a cross-sectional study. BMJ Open. 13(7). e064609–e064609. 6 indexed citations
5.
Li, Baocun, Xuan Wu, Yuxin Zhang, et al.. (2023). A NOVEL IMMUNOSTIMULATORY PD-L1/OX40 TETRAVALENT BISPECIFIC ANTIBODY FOR CANCER IMMUNOTHERAPY. PubMed Central. 6(Supplement_1). 2 indexed citations
6.
Zheng, Wei, et al.. (2021). A humanized monoclonal antibody targeting CD39 with novel mechanism for cancer treatment. SHILAP Revista de lepidopterología. 11. 100093–100093. 8 indexed citations
7.
Tripp, Catherine S., Carolyn A. Cuff, Andrew Campbell, et al.. (2017). RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. Advances in Therapy. 34(6). 1364–1381. 30 indexed citations
8.
Gao, Wenlong, Jingxin Zhang, Lei Zhang, et al.. (2016). Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs). Current Cancer Drug Targets. 16(6). 469–479. 9 indexed citations
9.
10.
McCole, Ruth B., Chamith Y. Fonseka, Amnon Koren, & Chengbin Wu. (2014). Abnormal Dosage of Ultraconserved Elements Is Highly Disfavored in Healthy Cells but Not Cancer Cells. PLoS Genetics. 10(10). e1004646–e1004646. 13 indexed citations
11.
Wu, Chengbin, Ying Hua, Sahana Bose, et al.. (2009). Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules. mAbs. 1(4). 339–347. 71 indexed citations
12.
Miller, Renee, Ramkrishna Sadhukhan, & Chengbin Wu. (2008). Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: The A-549 cell bioassay. Journal of Immunological Methods. 334(1-2). 134–141. 3 indexed citations
13.
Wu, Chengbin, Ying Hua, Christine Grinnell, et al.. (2007). Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nature Biotechnology. 25(11). 1290–1297. 253 indexed citations
14.
Wu, Chengbin, Paul Sakorafas, Renee Miller, et al.. (2003). IL-18 Receptor β-Induced Changes in the Presentation of IL-18 Binding Sites Affect Ligand Binding and Signal Transduction. The Journal of Immunology. 170(11). 5571–5577. 42 indexed citations
15.
Wang, Ninghai, Massimo Morra, Chengbin Wu, et al.. (2001). CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells. Immunogenetics. 53(5). 382–394. 54 indexed citations
16.
Sayós, Joan, Khuong B. Nguyen, Chengbin Wu, et al.. (2000). Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. International Immunology. 12(12). 1749–1757. 88 indexed citations
17.
Wu, Chengbin, Joan Sayós, Ninghai Wang, et al.. (2000). Genomic organization and characterization of mouse SAP , the gene that is altered in X-linked lymphoproliferative disease. Immunogenetics. 51(10). 805–815. 44 indexed citations
18.
Puett, David, Chengbin Wu, & Prema Narayan. (1998). The Tie that Binds: Design of Biologically Active Single-Chain Human Chorionic Gonadotropins and a Gonadotropin-Receptor Complex Using Protein Engineering1. Biology of Reproduction. 58(6). 1337–1342. 10 indexed citations
19.
Sayós, Joan, Chengbin Wu, M. Morra, et al.. (1998). The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395(6701). 462–469. 746 indexed citations breakdown →
20.
Wu, Chengbin, Prema Narayan, & David Puett. (1996). Protein Engineering of a Novel Constitutively Active Hormone-Receptor Complex. Journal of Biological Chemistry. 271(49). 31638–31642. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Boone Breakdown of academic impact, for papers by Masanori Shinohara Breakdown of academic impact, for papers by Thomas Matthes Breakdown of academic impact, for papers by Hideyuki Ikeda Breakdown of academic impact, for papers by Andreas Bruckbauer Breakdown of academic impact, for papers by Tadayuki Yago Breakdown of academic impact, for papers by Kei Takahashi Breakdown of academic impact, for papers by Elmar Endl Breakdown of academic impact, for papers by Björn Önfelt Breakdown of academic impact, for papers by Johannes W.G. Janssen
Rankless by CCL
2026